Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for abuse.

As part of a bipartisan coalition of 38 states and territories, California Attorney General Rob Bonta today urged the Food and Drug Administration (FDA) to take swift and decisive action against bad ...

At the end of the day, weight loss options, like any other health-related decisions, are very personal and must be made on a ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their employers.

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

US sweet protein startup Oobli has raised $18M and partnered with global ingredients giant Ingredion to develop ...